Perez-Viloria Miguel E, Lopez Kalei, Malik Fayeza, Yatham Puja, Lopez Olga, Oh Kei S, Alghamdi Sarah, Garcia Guillermo
Anesthesiology, Mount Sinai Medical Center, Miami, USA.
Anesthesiology, Florida International University, Herbert Wertheim College of Medicine, Miami, USA.
Cureus. 2022 Sep 17;14(9):e29274. doi: 10.7759/cureus.29274. eCollection 2022 Sep.
Transfusion-related acute lung injury (TRALI) following transfusion of all plasma-containing blood products is a rare but serious syndrome characterized by the acute onset of non-cardiogenic pulmonary edema with severe hypoxemia with or without symptoms of hypotension, pinkish frothy secretions, fever, and cyanosis. In this report, we present a case of a 66-year-old female with a medical history significant for hypertension, hyperlipidemia, hepatitis C, liver cirrhosis, tobacco use disorder, metastatic spindle cell carcinoma of the lung status post chemotherapy who developed TRALI after administration of one unit of platelets. Although a rare occurrence, there can be a considerable risk of TRALI following transfusion of all plasma-containing blood products and there is great importance in considering each patient's risk factors for TRALI development prior to blood product administration.
输注所有含血浆血液制品后发生的输血相关急性肺损伤(TRALI)是一种罕见但严重的综合征,其特征为非心源性肺水肿急性发作,伴有严重低氧血症,可伴有或不伴有低血压、粉红色泡沫样分泌物、发热和发绀症状。在本报告中,我们呈现了一例66岁女性病例,该患者有高血压、高脂血症、丙型肝炎、肝硬化、烟草使用障碍病史,曾患肺转移性梭形细胞癌并接受化疗,在输注一单位血小板后发生了TRALI。尽管发生率很低,但输注所有含血浆血液制品后发生TRALI的风险可能相当大,在输注血液制品前考虑每位患者发生TRALI的风险因素非常重要。